Avicanna (AVCNF), through its majority-owned subsidiary Santa Marta Golden Hemp, completed the first export of non-psychoactive CBD dominant cannabis flower to Switzerland. This export is a result of improvements directed by the Company in 2024, when it improved internal practices and enhanced the local infrastructure at SMGH to expand the portfolio of Aureus branded products with premium organic flower to meet the growing demand of medical cannabis flower in Europe and Australia. The Company is currently producing a range of proprietary and premium CBD, CBG and THC genetics for these markets. This export included three proprietary varieties which are a part of the Company’s portfolio of registered cannabis varieties in Colombia. This also marks the 20th international market for Aureus-branded products and 23rd market for all Avicanna products which further validates the Company’s expertise in navigating complex regulatory processes for its commercialization efforts internationally.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVCNF:
- Avicanna LATAM SAS and Harrington Wellness Launch re+PLAY CBD Brand in the U.S.
- Avicanna LATAM SAS partners with Harrington Wellness
- Avicanna Inc. Reports Q2 2025 Financial Results
- Avicanna Reports Q2 2025 Financial Results and Strategic Advancements
- Avicanna reports Q2 revenue $6.16M, up 1% vs. 2Q24